< Back to news

Groupe Berkem announces the strategic acquisition of i.Bioceuticals

Press release
  • Establishment of Groupe Berkem in North America
  • Expansion of the Group’s bio-based offer in the very promising Nutraceuticals market
  • Integration of an immediately accretive acquisition as of today

Blanquefort (France), 16 February 2023, at 6:00pm – Groupe Berkem (the “Group”), a leading player in bio-based chemicals (ISIN code: FR00140069V2 – Ticker: ALKEM), announced today the closing of the acquisition of i.Bioceuticals, Inc., the leading and exclusive North American distributor of nutritional ingredients from the Dutch company INC (International Nutrition Company), from INC.

Read more